James E. Fickenscher

Companies

• Zynerba PharmaceuticalsChief financial officer Sep 22, 2016 to Oct 11, 2023¹
• ANTARES PHARMA, INC.Chief financial officer Nov 18, 2014 to Jun 6, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ZPZynerba Pharmaceuticals ZYNE0 shares³Oct 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Oct 10, 2023U 425,000 shares of Zynerba Pharmaceuticals³
• Oct 10, 2023Granted 170,000 shares of Zynerba Pharmaceuticals³
• Oct 10, 2023U 123,087 shares of Zynerba Pharmaceuticals³
• Sep 13, 2023Sold 8,998 shares at $1.33 of Zynerba Pharmaceuticals⁴
• Sep 12, 2023Granted 31,200 shares of Zynerba Pharmaceuticals⁴
• Feb 8, 2023Shares withheld for tax 6,544 shares at $0.60 of Zynerba Pharmaceuticals⁵
• Feb 7, 2023Granted 22,547 shares of Zynerba Pharmaceuticals⁵
• Feb 1, 2023Shares withheld for tax 5,927 shares at $0.60 of Zynerba Pharmaceuticals⁶
• Jan 31, 2023Granted 21,073 shares of Zynerba Pharmaceuticals⁶
• Jan 24, 2023Granted 170,000 shares of Zynerba Pharmaceuticals⁷
• Jan 23, 2023Sold 17,769 shares at $0.60 of Zynerba Pharmaceuticals⁷
• Jul 19, 2022Sold 6,013 shares at $1.10 of Zynerba Pharmaceuticals⁸
• Jul 18, 2022Granted 20,800 shares of Zynerba Pharmaceuticals⁸
• Jan 26, 2022Granted 85,000 shares of Zynerba Pharmaceuticals⁹